Exploration Capital Fund, LP's Form 4 filing
Fresh Tracks Therapeutics, Inc. (FRTX) · filed Dec 6, 2023
- Accession no.
- 0001213900-23-093858
- Filed
- Dec 6, 2023, 9:45 PM ET
- Trade date
- Dec 4-6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $26.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital Fund, LPCIK 0001799866 | 10% Owner |
| Exploration Capital General Partner, LLCCIK 0002003481 | 10% Owner |
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | PPurchaseDisposed | −7,579 | $0.85 | −$6,442.15 | 677,579 | Direct | |
| Dec 5, 2023 | Common Stock | PPurchaseDisposed | −5,188 | $0.85 | −$4,409.8 | 682,767 | Direct | |
| Dec 6, 2023 | Common Stock | PPurchaseDisposed | −17,233 | $0.90 | −$15,509.7 | 700,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.